Goal-directed Resuscitative Interventions during Pediatric Inter-facility Transpo

儿科跨机构转运期间的目标导向复苏干预

基本信息

项目摘要

DESCRIPTION (provided by applicant): Recent advances in critical care medicine have dramatically improved morbidity and mortality of critical illness. Goal-directed therapy protocols have been instrumental in this change. Goal-directed therapy standardizes the rapid delivery of definitive care in illnesses such as SIRS (Systemic Inflammatory Response Syndrome) and head trauma. Although this treatment approach has been shown to improve clinical outcomes1,2, it has not been widely adopted outside academic medical centers. Further improvement in outcomes of critical illness is likely if goal-directed therapy is utilized early in the course of care. To facilitate this early adoption, goal-directed therapeutic protocols should be developed and implemented by specialized pediatric transport teams. We hypothesize that the institution of goal-directed therapy during pediatric inter- facility transport will improve the outcomes of critically ill children. The GRIPIT Trial (Goal-directed Resuscitative Interventions during Pediatric Inter-facility Transport) will compare outcomes of pediatric SIRS patients before and after the implementation of a goal-directed therapeutic protocol during transport. This will be the first test of goal-directed therapy in the transport environment. Data will be collected on pediatric SIRS patients transported by the Angel One Transport Team at Arkansas Children's Hospital before and after protocol implementation. Outcome measures will include length of hospital stay, length of intensive care unit (ICU) stay, incidence of multiple organ dysfunction syndrome (MODS), and required therapeutic interventions during ICU stay (TISS-28 scores). In addition, NIRS (Near-Infrared Spectroscopy) monitoring will be used as a cerebral and somatic oxygenation trend monitor, to determine its effectiveness as a resuscitation guide for pediatric SIRS during transport. NIRS trends are useful as a surrogate marker for systemic venous saturations, known to decrease with severe SIRS3. PUBLIC HEALTH RELEVANCE: The GRIPIT Trial will be the first test of goal-directed therapy in the transport environment. This study has the potential to change the current practice of pediatric inter-facility transport, and improve clinical outcomes of pediatric SIRS.
描述(由申请人提供):重症监护医学的最新进展已大大提高了重症疾病的发病率和死亡率。目标指导的治疗方案对这一变化有用。目标定向的治疗标准化了在SIRS(系统性炎症反应综合征)和头部创伤等疾病中快速提供确定的护理。尽管已证明这种治疗方法可以改善临床结局1,2,但在学术医疗中心以外没有被广泛采用。如果在护理过程中使用目标指导的治疗,则可能会进一步改善重症疾病的结果。 为了促进这种早期采用,应由专业的儿科运输团队制定和实施目标指导的治疗方案。我们假设小儿间交通期间的目标定向治疗机构将改善重症儿童的结果。 GRIPIT试验(小儿跨诊断期间的目标指导的复苏干预措施)将比较在运输过程中实施目标指导的治疗方案之前和之后的小儿SIRS患者的预后。这将是运输环境中目标定向治疗的首次测试。将收集有关在协议实施之前和之后,由阿肯色州儿童医院的Angel One运输团队运送的小儿SIRS患者。结果指标将包括住院时间,重症监护病房的长度(ICU)住院时间,多器官功能障碍综合征(MOD)的发生率以及ICU停留期间所需的治疗干预措施(Tiss-28分数)。 此外,NIRS(近红外光谱)监测将用作脑氧合趋势监测仪,以确定其作为运输过程中小儿SIR的复苏指南的有效性。 NIRS趋势可作为系统性静脉饱和度的替代标记物,已知会随着严重的SIRS3降低。 公共卫生相关性:Gripit试验将是运输环境中目标定向治疗的首次测试。这项研究有可能改变当前的小儿际交通运输的实践,并改善小儿SIR的临床结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Hugh STROUD其他文献

MICHAEL Hugh STROUD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Hugh STROUD', 18)}}的其他基金

Goal-directed Resuscitative Interventions during Pediatric Inter-facility Transpo
儿科跨机构转运期间的目标导向复苏干预
  • 批准号:
    8125098
  • 财政年份:
    2010
  • 资助金额:
    $ 22.05万
  • 项目类别:

相似国自然基金

采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
  • 批准号:
    32371047
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
  • 批准号:
    72303205
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
  • 批准号:
    12305261
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
  • 批准号:
    62301339
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
  • 批准号:
    72304103
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
  • 批准号:
    10747551
  • 财政年份:
    2023
  • 资助金额:
    $ 22.05万
  • 项目类别:
Use of electronic health records in underserved communities in Florida
在佛罗里达州服务欠缺的社区使用电子健康记录
  • 批准号:
    10580502
  • 财政年份:
    2023
  • 资助金额:
    $ 22.05万
  • 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
  • 批准号:
    10707047
  • 财政年份:
    2022
  • 资助金额:
    $ 22.05万
  • 项目类别:
Developing a PREPARE for Your Care delivery system to enhance adoption by healthcare organizations
开发 PREPARE for Your Care 交付系统以提高医疗机构的采用率
  • 批准号:
    10546110
  • 财政年份:
    2022
  • 资助金额:
    $ 22.05万
  • 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
  • 批准号:
    10436056
  • 财政年份:
    2022
  • 资助金额:
    $ 22.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了